Ortho Clinical Diagnostics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Ortho Clinical Diagnostics (Nasdaq: OCDX) announced two forthcoming investor conferences: the UBS Virtual Global Healthcare Conference on May 24, 2021, at 11:00 am ET, and the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 1:30 pm ET. The presentations will be accessible via a live webcast on the company’s website. With a legacy of over 80 years, Ortho is a leader in the IVD sector, impacting over 800,000 patients daily by providing innovative diagnostic solutions and ensuring fast, accurate results.

RARITAN, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to present in two upcoming investor conferences:

• UBS Virtual Global Healthcare Conference on Monday, May 24, 2021 at 11:00am ET
• Goldman Sachs 42^nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 1:30pm ET

Interested parties can access a live webcast and replay of each presentation on the “Investors” portion of the Company’s website at https://ir.orthoclinicaldiagnostics.com/, under the “Events” section. Management will also be hosting individual meetings with investors at both of the conferences.

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies.

More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test is a Life™, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate, and reliable. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs.

From launching the first product to determine Rh+ or Rh- blood type, developing the world’s first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology and marketing the first U.S. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years.

The company is powered by Ortho Care™, an award-winning, holistic service and support program that ensures best-in-class technical, field and remote service and inventory support to laboratories in more than 130 countries and territories around the globe.  

For more information, visit Ortho’s website or social media channels: LinkedIn, Twitter, Facebook and YouTube. 

Investors:

IR@orthoclinicaldiagnostics.com

Media:

media@orthoclinicaldiagnostics.com

FAQ

What investor conferences is Ortho Clinical Diagnostics attending in 2021?

Ortho Clinical Diagnostics will present at the UBS Virtual Global Healthcare Conference on May 24, 2021, and at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021.

What time does the UBS Virtual Global Healthcare Conference presentation start?

The UBS Virtual Global Healthcare Conference presentation starts at 11:00 am ET on May 24, 2021.

How can I access the presentations by Ortho Clinical Diagnostics?

The presentations can be accessed via a live webcast on the 'Investors' section of Ortho Clinical Diagnostics' website.

How many patients are impacted daily by Ortho Clinical Diagnostics' tests?

Ortho Clinical Diagnostics impacts more than 800,000 patients globally with its diagnostic tests each day.

What is the ticker symbol for Ortho Clinical Diagnostics?

The ticker symbol for Ortho Clinical Diagnostics is OCDX.